Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,

    Updates to Anti-Coagulation Video Channel

    Not available for members in the UK, US, and Canada

    Three new videos have been added to the Anti-Coagulation Video Channel as part of a
    series of regular updates to this resource. In each video, experts discuss the use of
    novel oral anticoagulants in stroke and DVT. New clinical videos will be added
    regularly, so ensure you return often to make the most of this free resource.

    This resource has been developed in collaboration with Boehringer Ingelheim, who provided the videos.

  • ,

    New Type 2 Diabetes CME now available

    A new CME activity ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in
    Combination with Insulin’ has been added to the Type 2 Diabetes Learning Zone.
    Complete the five modules to enhance your understanding of the combination
    therapies available for treating type 2 diabetes.

  • ,COPD whats new ATS 2015

    ATS 2015 symposium materials added to
    COPD Knowledge Centre

    Speaker slides and a video from the Novartis-sponsored symposium ‘Are we gaining the
    maximum benefit from bronchodilators in COPD?’ have been added to the COPD Knowledge
    Centre. The session was held at the American Thoracic Society (ATS) conference 2015 to
    highlight the fundamental role of bronchodilators in COPD management, and presented
    key drug data including efficacy and safety of some of the latest COPD therapies.

  • ,Whats New CSU

    Updates to Chronic Spontaneous Urticaria
    Knowledge Centre

    Video presentations of faculty experts speaking at the 23rd World Congress of
    Dermatology (WCD) 2015 have been added to the Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre. Topics discussed include diagnosis, burden and an overall clinical
    picture of urticaria.

  • ,Hyperammonaemia Knowledge Centre

    Launch of Hyperammonaemia Knowledge Centre

    Could you recognise the signs and symptoms of hyperammonaemia?
    Healthcare professionals have FREE access to a new educational resource providing up
    to date disease awareness information, treatment options, video channel and resources
    to help them quickly identify and treat this potentially life-threatening condition.

Latest News

FDA approves Fluad (MF59 adjuvanted seasonal influenza vaccine) for influenza- NVS Influenza Vaccines


The FDA has approved Fluad (MF59 adjuvanted seasonal influenza vaccine), from NVS Influenza Vaccines, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A ...

EU expands indication of Xalkori (crizotinib) to include previously untreated patients with ALK-positive NSCLC- Pfizer


The European Commission has approved a label update to expand use of Xalkori (crizotinib), from Pfizer, to first-line treatment of adults with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). The Summary of ...

EU gives CE mark approval to i-cor Synchronized Cardiac Assist System for heart failure- Xenios


Xenios has announced that its i-cor Synchronized Cardiac Assist System has received CE marking and can now be sold in Europe as the world’s first heartbeat-synchronized cardiac assist for cardiogenic shock and high-risk interventions in patients with ...

FDA approves Portrazza (necitumumab) to treat metastatic squamous NSCLC- Eli Lilly


Eli Lilly and Company announced that the FDA has approved Portrazza (necitumumab injection for intravenous use, 800 mg/50 mL), in combination with gemcitabine and cisplatin, as the first biologic for the first-line treatment of people with metastatic ...

NICE rejects Yondelis (trabectedin) as a treatment for ovarian cancer- Pharma Mar.


The National Institute for Health and Care Excellence ( NICE) again did not recommend Yondelis (trabectedin) from Pharma Mar plus pegylated liposomal doxorubicin (PLDH)in its preliminary guidance as a treatment for ovarian cancer in patients ...

European Commission approves Genvoya (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir alafenamide 10 mg or E/C/F/TAF) to treat HIV.-Gilead Sciences


Gilead Sciences, Inc. announced that the European Commission has granted marketing authorization for the once-daily single tablet regimen Genvoya (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir alafenamide 10 mg or E/C/F/TAF) ...

FDA approves Opdivo (nivolumab) to treat advanced renal cell carcinoma- BMS + Ono Pharma


BMS announced that the FDA has approved Opdivo (nivolumab) injection, for intravenous use, for the treatment of patients with advanced renal cell carcinoma (RCC) who have received prior anti-angiogenic therapy. This announcement marks the approval of ...

Recent Updates


Clinical Guidelines

Management of Obesity in Adults: European Clinical Practice Guidelines

British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia

Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015

Coeliac disease: recognition, assessment and management

Medical Journals

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.

Three-Year Outcomes of Cranial Nerve Stimulation for Obstructive Sleep Apnea: The STAR Trial.

Dapagliflozin combination therapy in type 2 diabetes mellitus.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors